Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Comparing different nanofat procedures on scars: role of the stromal vascular fraction and its clinical implications.

Gentile P., Scioli MG., Bielli A., Orlandi A., Cervelli V.

Laboratory Study on Scar, published in Regen Med (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Regen Med (2017)
Country
England
Reported sample size
—
Source database
PubMed
PMID
29236575
DOI
10.2217/rme-2017-0076
Citations
71

Abstract (original English)

Aim Recently, a new fat grafting technique termed 'nanofat grafting' was proposed which improved tissue repair by the stem cells contained in the stromal vascular fraction (SVF) of nanofat. Here, we reported the clinical outcomes of different nanofat procedures in the treatment of scars in relation with SVF cell yield. Methods Three different modified nanofat grafting procedures (supercharged-, evo- and centrifuged-modified nanofat) were compared with the classic nanofat method, and histological analysis was performed to assess skin regeneration. Residual nanofat samples were analyzed to determine SVF immunophenotype and yield from each procedure. Results Supercharged-modified nanofat gave the best results in terms of clinical outcome and SVF yield. Histological analysis revealed similar skin regeneration in all treatments. Conclusion This work suggested a positive correlation between SVF yield and clinical outcomes in the nanofat treatment of scars.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdultAgedCell DifferentiationCells, CulturedCicatrixFemaleHumansImmunophenotypingMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research